Durect Corp. Stock
Durect Corp. Stock
Our community identified positive and negative aspects for Durect Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Durect Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Durect Corp. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Durect Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Durect Corp. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -6.280% | 21.470% | 19.448% | 27.453% | 28.542% | 131.113% | 8.339% |
| Evolus Inc | -1.240% | -5.743% | -16.491% | -50.417% | -12.661% | -38.182% | 32.554% |
| Champions Oncology Inc | - | 0.901% | 8.738% | 17.647% | -3.448% | 42.132% | -35.260% |
Comments
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat